More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week's podcast.
Medscape’s Post
More Relevant Posts
-
✈️ Heading to #IDWeek2024? Elevate your knowledge on RSV infections. 📚 Learn how to recommend vaccines, engage in shared decision-making, and emphasize 💉 vaccine importance for at-risk individuals.📍 http://ms.spr.ly/6046mFiAi
To view or add a comment, sign in
-
📣 Explore the power 🔋 of mRDTs at #IDWeek2024! Gain expertise in using these tools to detect pathogens and optimize care with PCR results. 🔬 Boost your confidence in collaborating with care teams for better infection management. Join us: http://ms.spr.ly/6043mFeW1
To view or add a comment, sign in
-
In this CME-accredited, live, and interactive social media event, a panel of 3 oncology experts will review key emerging prostate cancer data released at the 2024 Congress of the European Society for Medical Oncology (ESMO). - - - - - Moderator: Neal Shore, MD, FACS Faculty: Rana R. McKay, MD, FASCO Faculty: Bertrand Tombal, MD, PhD - - - - - Earn free 0.50 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event. Click the link to view the Accreditation and Disclosure details before participating: https://lnkd.in/eZfNUfUb. Supported by an independent educational grant from Bayer.
Prostate Cancer Highlights: Expert Review of European Oncology Meeting
www.linkedin.com
To view or add a comment, sign in
-
⭐ 𝐋𝐈𝐕𝐄 𝐈𝐍 𝟏 𝐇𝐎𝐔𝐑! Don't miss this LIVE #ESMO recap to review key emerging prostate cancer data + earn free CME. Your Q+A welcome alongside this exclusive, expert commentary. ➡️ http://ms.spr.ly/6040m9B7a
To view or add a comment, sign in
-
Dr. Jarushka Naidoo discusses advances in precision oncology as it applies to NSCLC in the third of the expert series from the clinical advances in PRecision Oncology: Medical Innovations and Scientific Exchange (PROMISE). http://ms.spr.ly/6043m0lb7
Dr. Jarushka Naidoo - Precision Oncology in NSCLC
medscape.org
To view or add a comment, sign in
-
Because screening [for MASLD/MASH] isn’t widespread, patients often aren’t diagnosed until they experience complications of cirrhosis. 70% of people presenting for the first time with a complication of cirrhosis, that is also the first time their liver disease is being diagnosed. Arun Sanyal, MD http://ms.spr.ly/6048mvR8i
Clinical Advances in MASH: A Guide to Managing Metabolic-Dysfunction Associated Steatohepatitis
medscape.org
To view or add a comment, sign in
-
"Diabetes can cause cirrhosis!" A critical message from Naim Alkhouri, MD, FAASLD, who wants "all of my primary care physician colleagues to actually spread the word" and monitor liver health for patients with diabetes. Watch this key MASH chat, including Jay Shubrook. 👉 http://ms.spr.ly/6048maznC
MASH - Diabetes Can Cause Cirrhosis - Alkhouri.mp4
To view or add a comment, sign in
-
Fresh from #AAP2024, Drs Stukus and Hernandez-Trujillo share how to help parents navigate the most appropriate treatment for a child's allergic rhinitis. Stressing clarification of the diagnosis first, they discuss options including 2nd-gen antihistamines and intranasal corticosteroids. Watch in full + earn CME 👉 http://ms.spr.ly/6048moGr0
Antihistamines in Children - Stukos and Trujillo.mp4
To view or add a comment, sign in
-
Don't miss this LIVE conversation between Drs Feyma and Armstrong as they share how to recognize symptoms, assess and diagnose, and refer a patient suspected of having Rett syndrome to specialty care. - - - - - Faculty: Dallas Armstrong, MD Assistant Professor Department of Pediatrics and Neurology Medical Director, Rett Syndrome and Related Disorders Clinic UT Southwestern Medical Center Dallas, Texas Faculty: Timothy Feyma, MD Adjunct Professor of Pediatrics University of Minnesota Child Neurologist Co-Director, Rett Syndrome Clinic Co-Director, Complex Movement Disorder Clinic Gillette Childrens Specialty Healthcare St. Paul, Minnesota - - - - - Earn free 0.25 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event. Supported by an independent educational grant from ACADIA Pharmaceuticals.
When to Consider Rett Syndrome in Practice: A Clinical Conversation
www.linkedin.com
To view or add a comment, sign in
-
Join us to gain some education credit and improve your ability to adopt biosimilars through identifying patients with diabetes for whom these agents would be an appropriate treatment option. http://ms.spr.ly/6042ma2n0
The Impact of Biosimilar Products for People Living With Diabetes
medscape.org
To view or add a comment, sign in
128,662 followers